Breast Elasticity Imaging During Neoadjuvant Chemotherapy

Recruiting now · Not applicable

Conditions studied: Breast Cancer

In brief

For this study, the investigators propose investigation of a new imaging technique, Harmonic Motion Imaging (HMI), and the evaluation of its potential role in prediction of breast cancer response to neoadjuvant chemotherapy (NACT). The investigators hypothesize that changes in HMI parameters will predict response to neoadjuvant systemic therapy in early-stage breast cancer.

Key facts

Study ID

NCT04824027

Run by

Columbia University

People needed

50

Starts

2021-06-14

Expected to finish

2026-05-01

Last updated by the study team

2025-05-29

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Women age ≥18
• Deemed eligible to receive neoadjuvant systemic therapy as per the treating physician, with the dose and schedule deemed appropriate by the treating physician.
• Any stage invasive breast cancer provided the primary breast tumor size is ≥ 4 mm

You may not qualify if…

• Patient is pregnant or lactating
• Presence of breast implants
• History of laser or radiation therapy to the affected breast

Where it is running

• Columbia University Irving Medical Center/NYP — New York, New York, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.